Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34386 | 112 | 49.1 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
10 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 | 39664 |
34386 | 1 | MOL BIOL VIRAL ONCOGENESIS//HYPERVARIABLE EPITOPE CONSTRUCTS//LENTIVIRAL VLP | 112 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOL BIOL VIRAL ONCOGENESIS | address | 969375 | 7% | 44% | 8 |
2 | HYPERVARIABLE EPITOPE CONSTRUCTS | authKW | 545279 | 2% | 100% | 2 |
3 | LENTIVIRAL VLP | authKW | 545279 | 2% | 100% | 2 |
4 | VIRAL ONCOGENESIS IMMUNOTHER IES | address | 545279 | 2% | 100% | 2 |
5 | AGR MINIST VET PUBL HLTH | address | 272639 | 1% | 100% | 1 |
6 | ARTIFICIAL INUMMOGENS | authKW | 272639 | 1% | 100% | 1 |
7 | ARTIFICIAL VIRUS LIKE PARTICLES | authKW | 272639 | 1% | 100% | 1 |
8 | B LYMPHOCYTE EPITOPE | authKW | 272639 | 1% | 100% | 1 |
9 | BASAL PORTION | authKW | 272639 | 1% | 100% | 1 |
10 | BIOCHEM VIRUS MOLEC BIOL GRP | address | 272639 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 1883 | 31% | 0% | 35 |
2 | Immunology | 968 | 45% | 0% | 50 |
3 | Medicine, Research & Experimental | 379 | 22% | 0% | 25 |
4 | Infectious Diseases | 106 | 10% | 0% | 11 |
5 | Mathematical & Computational Biology | 19 | 3% | 0% | 3 |
6 | Biotechnology & Applied Microbiology | 14 | 6% | 0% | 7 |
7 | Medical Laboratory Technology | 10 | 2% | 0% | 2 |
8 | Biochemistry & Molecular Biology | 8 | 12% | 0% | 13 |
9 | Biophysics | 5 | 4% | 0% | 4 |
10 | Pharmacology & Pharmacy | 4 | 6% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL BIOL VIRAL ONCOGENESIS | 969375 | 7% | 44% | 8 |
2 | VIRAL ONCOGENESIS IMMUNOTHER IES | 545279 | 2% | 100% | 2 |
3 | AGR MINIST VET PUBL HLTH | 272639 | 1% | 100% | 1 |
4 | BIOCHEM VIRUS MOLEC BIOL GRP | 272639 | 1% | 100% | 1 |
5 | E AFRICAN AIDS | 272639 | 1% | 100% | 1 |
6 | EMOROY VACCINE | 272639 | 1% | 100% | 1 |
7 | EXPT IMMUNOTHER Y MOL BIOL ONCOGENESIS UNI | 272639 | 1% | 100% | 1 |
8 | ICSCWL | 272639 | 1% | 100% | 1 |
9 | IMMUNOTHER EUT DRUG DEV | 272639 | 1% | 100% | 1 |
10 | MED UNIT 163 | 272639 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 4899 | 16% | 0% | 18 |
2 | VIROLOGICA SINICA | 3539 | 1% | 1% | 1 |
3 | EXPERT REVIEW OF VACCINES | 3501 | 4% | 0% | 4 |
4 | JOURNAL OF TRANSLATIONAL MEDICINE | 1880 | 4% | 0% | 4 |
5 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 1831 | 5% | 0% | 6 |
6 | AMERICAN JOURNAL OF NONINVASIVE CARDIOLOGY | 1681 | 1% | 1% | 1 |
7 | CURRENT HIV RESEARCH | 1326 | 2% | 0% | 2 |
8 | VIROLOGY | 932 | 7% | 0% | 8 |
9 | KOREAN JOURNAL OF LABORATORY MEDICINE | 675 | 1% | 0% | 1 |
10 | MOLECULAR IMMUNOLOGY | 615 | 4% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BUONAGURO, L , TAGLIAMONTE, M , VISCIANO, ML , TORNESELLO, ML , BUONAGURO, FM , (2013) DEVELOPMENTS IN VIRUS-LIKE PARTICLE-BASED VACCINES FOR HIV.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 2. P. 119-127 | 29 | 26% | 5 |
2 | TAGLIAMONTE, M , VISCIANO, ML , TORNESELLO, ML , DE STRADIS, A , BUONAGURO, FM , BUONAGURO, L , (2010) CONSTITUTIVE EXPRESSION OF HIV-VLPS IN STABLY TRANSFECTED INSECT CELL LINE FOR EFFICIENT DELIVERY SYSTEM.VACCINE. VOL. 28. ISSUE 39. P. 6417-6424 | 17 | 33% | 9 |
3 | BUONAGURO, L , TORNESELLO, ML , JEWIS, GK , BUONAGURO, FM , (2009) SHORT COMMUNICATION: LIMITED INDUCTION OF IL-10 IN PBMCS FROM HIV-INFECTED SUBJECTS TREATED WITH HIV-VLPS.AIDS RESEARCH AND HUMAN RETROVIRUSES. VOL. 25. ISSUE 8. P. 819 -822 | 12 | 43% | 4 |
4 | MONACO, A , MARINCOLA, FM , SABATINO, M , POS, Z , TORNESELLO, ML , STRONCEK, DF , WANG, E , LEWIS, GK , BUONAGURO, FM , BUONAGURO, L , (2009) MOLECULAR IMMUNE SIGNATURES OF HIV-1 VACCINES IN HUMAN PBMCS.FEBS LETTERS. VOL. 583. ISSUE 18. P. 3004 -3008 | 10 | 45% | 8 |
5 | BUONAGURO, L , TAGLIAMONTE, M , TORNESELLO, ML , BUONAGURO, FM , (2011) DEVELOPMENTS IN VIRUS-LIKE PARTICLE-BASED VACCINES FOR INFECTIOUS DISEASES AND CANCER.EXPERT REVIEW OF VACCINES. VOL. 10. ISSUE 11. P. 1569-1583 | 29 | 13% | 28 |
6 | TAGLIAMONTE, M , VISCIANO, ML , TORNESELLO, ML , DE STRADIS, A , BUONAGURO, FM , BUONAGURO, L , (2011) HIV-GAG VLPS PRESENTING TRIMERIC HIV-1 GP140 SPIKES CONSTITUTIVELY EXPRESSED IN STABLE DOUBLE TRANSFECTED INSECT CELL LINE.VACCINE. VOL. 29. ISSUE 31. P. 4913-4922 | 15 | 26% | 11 |
7 | BUONAGURO, L , TORNESELLO, ML , BUONAGURO, FM , (2010) VIRUS-LIKE PARTICLES AS PARTICULATE VACCINES.CURRENT HIV RESEARCH. VOL. 8. ISSUE 4. P. 299-309 | 26 | 15% | 20 |
8 | PETRIZZO, A , TORNESELLO, M , BUONAGURO, FM , BUONAGURO, L , (2012) IMMUNOGENOMICS APPROACHES FOR VACCINE EVALUATION.JOURNAL OF IMMUNOTOXICOLOGY. VOL. 9. ISSUE 3. P. 236 -240 | 8 | 40% | 2 |
9 | PETRIZZO, A , TAGLIAMONTE, M , TORNESELLO, M , BUONAGURO, FM , BUONAGURO, L , (2014) SYSTEMS VACCINOLOGY FOR CANCER VACCINE DEVELOPMENT.EXPERT REVIEW OF VACCINES. VOL. 13. ISSUE 6. P. 711-719 | 16 | 17% | 0 |
10 | VISCIANO, ML , TAGLIAMONTE, M , TORNESELLO, ML , BUONAGURO, FM , BUONAGURO, L , (2012) EFFECTS OF ADJUVANTS ON IGG SUBCLASSES ELICITED BY VIRUS-LIKE PARTICLES.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 10. ISSUE . P. - | 13 | 16% | 22 |
Classes with closest relation at Level 1 |